Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.77 - $1.16 $11,655 - $17,558
-15,137 Reduced 56.68%
11,571 $9,000
Q1 2023

May 15, 2023

BUY
$0.91 - $2.63 $24,304 - $70,242
26,708 New
26,708 $24,000
Q2 2022

Aug 15, 2022

SELL
$1.47 - $2.94 $16,325 - $32,651
-11,106 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$2.72 - $5.97 $4,109 - $9,020
-1,511 Reduced 11.98%
11,106 $33,000
Q4 2021

Feb 14, 2022

BUY
$5.17 - $8.65 $65,229 - $109,137
12,617 New
12,617 $71,000
Q1 2021

May 17, 2021

SELL
$4.3 - $7.48 $96,711 - $168,232
-22,491 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$4.25 - $8.14 $95,586 - $183,076
22,491 New
22,491 $96,000

About Edesa Biotech, Inc.


  • Ticker EDSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,462,300
  • Market Cap $32.3M
  • Description
  • Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...
More about EDSA
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.